CrossRef G2E3 Suppresses the TumorKilling Function of CD8+ T Cells in Hepatocellular Carcinoma by Boosting CLCN2 Ubiquitination Fan Zhou, Ting Chen, Xingguo Tan, Jun Yu, Mengzhi Xiao, Jun Guo The FASEB Journal .2026;[Epub] CrossRef Tumor burden score determines survival benefit of anatomic resection in hepatocellular carcinoma: A multicenter propensity-matched study Shujie Pang, Yang Shi, Minjun Jiang, Qingwang Ye, Xin Yan, Zhe Sun, Xingrui Kou, Xiaoxiang Chen, Hui SiMa, Yiming Chen, Yingcheng Yang, Ning Yang European Journal of Surgical Oncology .2026
E., Droog, S
Absolute contraindications to GLP-1 receptor agonists with the boxed warning include patients with a personal history of MTC, family history of MTC, or known MEN 2 syndrome
Its three FDA approvals, proven cardiovascular benefit in the SELECT trial, oral formulation option, and extensive post-marketing data make it the reference against which all next-generation compounds must be measured
Researchers havent yet quantified the exact effect of Ozempic and other GLP-1 agonists on fertility
The format respects the user's schedule, allowing for consistent engagement even on busy days